BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6368424)

  • 1. Hepatotoxicity of the combination of rifampin-ethionamide in the treatment of multibacillary leprosy.
    Pattyn SR; Janssens L; Bourland J; Saylan T; Davies EM; Grillone S; Feracci C
    Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):1-6. PubMed ID: 6368424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined regimens of one year duration in the treatment of multibacillary leprosy--II. Combined regimens with rifampicin administered during 6 months.
    Pattyn SR; Groenen G; Janssens L; Deverchin J; Ghys P
    Lepr Rev; 1989 Jun; 60(2):118-23. PubMed ID: 2671560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory treatment of multibacillary leprosy with a regimen of 8 months duration.
    Pattyn SR; Bourland J; Kazeze
    Lepr Rev; 1992 Mar; 63(1):36-40. PubMed ID: 1569814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multi-drug therapy trials for leprosy in Senegal: first observations relative to liver tolerance of multibacillary patients. Therapeutic consequences].
    Millan J; Roux G; Loko S; Naudin JC; Boucher P; Bodian M; Camara M; Moreira-Diop T; Grosset J
    Acta Leprol; 1986; 4(4):427-44. PubMed ID: 3296613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis in leprosy patients treated by a daily combination of dapsone, rifampin, and a thioamide.
    Cartel JL; Millan J; Guelpa-Lauras CC; Grosset JH
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):461-5. PubMed ID: 6686970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
    Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
    Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Supervised bimonthly quadruple chemotherapy in 72 paucibacillary leprosy patients in French Guyana].
    Jamet P; Robin Y
    Acta Leprol; 1988; 6(1):35-44. PubMed ID: 3051853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatotoxicity of the daily combination of 5 mg/kg prothionamide + 10 mg/kg rifampin.
    Cartel JL; Naudillon Y; Artus JC; Grosset JH
    Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):15-8. PubMed ID: 3998559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy.
    Reeve PA; Ala J; Hall JJ
    J Trop Med Hyg; 1992 Aug; 95(4):266-70. PubMed ID: 1386634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new plan in the campaign against leprosy in Anjouan. Preliminary results].
    Grillone S; Pattyn SR
    Acta Leprol; 1986; 4(4):453-60. PubMed ID: 3296616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial of two single-dose treatments for paucibacillary leprosy.
    Pattyn SR; Ghys P; Janssens L; Tshilumba K; Kuykens L; Karibushi N; Denis P
    Lepr Rev; 1994 Mar; 65(1):45-57. PubMed ID: 8201835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acceptability, compliance and tolerance of daily polychemotherapy by leprosy patients in Guadeloupe].
    Cartel JL; Gallais JJ; Grosset JH
    Acta Leprol; 1985; 3(4):339-55. PubMed ID: 3913270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis and multi-drug therapy in leprosy with special reference to prothionamide.
    Kar HK; Balakrishnan S; Vasantha Kumar G; Sirumban P; Roy RG
    Indian J Lepr; 1985; 57(1):78-89. PubMed ID: 3839828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of combined treatments comprising 6 months' administration of rifampicin in multibacillary leprosy].
    Pattyn SR; Husser JA; Saint-André P
    Acta Leprol; 1986; 4(4):445-6. PubMed ID: 3296614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of multibacillary leprosy with a regimen of 13 weeks duration.
    Pattyn SR; Groenen G; Janssens L; Kuykens L; Mputu LB
    Lepr Rev; 1992 Mar; 63(1):41-6. PubMed ID: 1569815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of different regimens in multibacillary leprosy.
    Pattyn SR
    Lepr Rev; 1986; 57 Suppl 3():265-71. PubMed ID: 3553815
    [No Abstract]   [Full Text] [Related]  

  • 19. [5-year assessment of daily multi-drug therapy of leprosy in Guadeloupe since 1980].
    Cartel JC; Gallais JJ; Naudillon Y; Millan J; Grosset JH
    Acta Leprol; 1986; 4(4):415-25. PubMed ID: 3296612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The hepatotoxicity of ethionamide remains a topical subject. Apropos of a case of acute hepatitis].
    See A; Hervio P; Bouvry M
    Ann Gastroenterol Hepatol (Paris); 1986; 22(3):129-30. PubMed ID: 3729286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.